Strain variation in treatment and prevention of human prion diseases
- 1 January 2020
- book chapter
- Published by Elsevier
- Vol. 175, 121-145
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Behavior of Prions in the Environment: Implications for Prion BiologyPLOS Pathogens, 2013
- Relationship between Conformational Stability and Amplification Efficiency of PrionsBiochemistry, 2011
- Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to BioassaysPLOS Pathogens, 2010
- Distinct Stability States of Disease-Associated Human Prion Protein Identified by Conformation-Dependent ImmunoassayJournal of Virology, 2010
- Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cellsMolecular Neurodegeneration, 2010
- Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant PrionsPLOS Pathogens, 2009
- Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trialThe Lancet Neurology, 2009
- A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brainsProceedings of the National Academy of Sciences, 2008
- The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion InfectionPLOS ONE, 2008
- Enhanced Antiscrapie Effect Using Combination Drug TreatmentAntimicrobial Agents and Chemotherapy, 2006